BioProcess Insider - News BioProcess International

Fujifilm Dio signs long term supply deal and buys plant from Atara

Fujifilm Diosynth Biotechnologies will buy Atara Biotherapeutics’ T-Cell operations and facility in Thousand Oaks, California for $100 million. The deal will also see the contract development and manufacturing organization (CDMO) sign a long-term supply agreement covering both clinical ...

CDMO Arranta buys Cytiva single-use tech for mRNA production
Live biologics CDMO Arranta Bio has bought a single-use manufacturing platform from Cytiva for the production of mRNA vaccines. The pur ...
Novartis looks to gene therapy 3.0 with an eye on lowering COGS
Novartis is confident the manufacturing costs of gene therapies will fall as it improves processes and brings on board next generation technologi ...
64x Bio bags $55m in funding to drive cell production tech
64x Bio has received $55 million in a series A round of fundraising to fund the expansion of its VectorSelect platform. According to 64x Bio, ...
Excellos: ‘There is no better time to enter cell therapy CDMO space’
With the San Diego Blood Bank at its foundation and $15 million of funding in hand, Excellos launches itself in the cell therapy contract ma ...